These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8895819)

  • 1. Relationships among oxidation of low-density lipoprotein, antioxidant protection, and atherosclerosis.
    Esterbauer H; Schmidt R; Hayn M
    Adv Pharmacol; 1997; 38():425-56. PubMed ID: 8895819
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipoprotein oxidation: mechanistic aspects, methodological approaches and clinical relevance.
    Stocker R
    Curr Opin Lipidol; 1994 Dec; 5(6):422-33. PubMed ID: 7712047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased susceptibility of LDL to in vitro oxidation in patients on maintenance hemodialysis: effects of fish oil and vitamin E administration.
    Panzetta O; Cominacini L; Garbin U; Fratta Pasini A; Gammaro L; Bianco F; Davoli A; Campagnola M; De Santis A; Pastorino AM
    Clin Nephrol; 1995 Nov; 44(5):303-9. PubMed ID: 8605710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased oxidation resistance of atherogenic plasma lipoproteins at high vitamin E levels in non-vitamin E supplemented men.
    Porkkala-Sarataho E; Nyyssönen K; Salonen JT
    Atherosclerosis; 1996 Jul; 124(1):83-94. PubMed ID: 8800496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma and LDL levels of major lipophilic antioxidants are similar in patients with advanced atherosclerosis and age-matched controls.
    Cleary J; Mohr D; Adams MR; Celermajer DS; Stocker R
    Free Radic Res; 1997 Feb; 26(2):175-82. PubMed ID: 9257129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-density lipoprotein oxidation, antioxidants, and atherosclerosis: a clinical biochemistry perspective.
    Jialal I; Devaraj S
    Clin Chem; 1996 Apr; 42(4):498-506. PubMed ID: 8605665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The resistance of low density lipoprotein to oxidation promoted by copper and its use as an index of antioxidant therapy.
    O'Leary VJ; Tilling L; Fleetwood G; Stone D; Darley-Usmar V
    Atherosclerosis; 1996 Jan; 119(2):169-79. PubMed ID: 8808494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular action of vitamin E in lipoprotein oxidation: implications for atherosclerosis.
    Thomas SR; Stocker R
    Free Radic Biol Med; 2000 Jun; 28(12):1795-805. PubMed ID: 10946221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma LDL oxidation leads to its aggregation in the atherosclerotic apolipoprotein E-deficient mice.
    Maor I; Hayek T; Coleman R; Aviram M
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2995-3005. PubMed ID: 9409286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of combined supplementation with alpha-tocopherol, ascorbate, and beta carotene on low-density lipoprotein oxidation.
    Jialal I; Grundy SM
    Circulation; 1993 Dec; 88(6):2780-6. PubMed ID: 8252691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary antioxidants inhibit development of fatty streak lesions in the LDL receptor-deficient mouse.
    Crawford RS; Kirk EA; Rosenfeld ME; LeBoeuf RC; Chait A
    Arterioscler Thromb Vasc Biol; 1998 Sep; 18(9):1506-13. PubMed ID: 9743241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified forms of low-density lipoprotein and atherosclerosis.
    Steinberg D
    J Intern Med; 1993 Mar; 233(3):227-32. PubMed ID: 8450290
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical trials of vitamin E in coronary artery disease: is it time to reconsider the low-density lipoprotein oxidation hypothesis?
    Heinecke JW
    Curr Atheroscler Rep; 2003 Mar; 5(2):83-7. PubMed ID: 12573190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole plasma oxidation assay as a measure of lipoprotein oxidizability.
    Kontush A; Spranger T; Reich A; Djahansouzi S; Karten B; Braesen JH; Finckh B; Kohlschütter A; Beisiegel U
    Biofactors; 1997; 6(2):99-109. PubMed ID: 9259991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of an in vivo oxidized LDL to LDL oxidation and its association with dense LDL subpopulations.
    Sevanian A; Hwang J; Hodis H; Cazzolato G; Avogaro P; Bittolo-Bon G
    Arterioscler Thromb Vasc Biol; 1996 Jun; 16(6):784-93. PubMed ID: 8640406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidized low-density lipoprotein and atherosclerosis.
    Devaraj S; Jialal I
    Int J Clin Lab Res; 1996; 26(3):178-84. PubMed ID: 8905449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced susceptibility of low-density lipoproteins to oxidation in coronary bypass patients with progression of atheroscerosis.
    De Rijke YB; Verwey HF; Vogelezang CJ; Van Der Velde EA; Princen HM; Van Der Laarse A; Bruschke AV; Van Berkel TJ
    Clin Chim Acta; 1995 Dec; 243(2):137-49. PubMed ID: 8747490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antioxidants decreases the intensification of low density lipoprotein in vivo peroxidation during therapy with statins.
    Lankin VZ; Tikhaze AK; Kukharchuk VV; Konovalova GG; Pisarenko OI; Kaminnyi AI; Shumaev KB; Belenkov YN
    Mol Cell Biochem; 2003 Jul; 249(1-2):129-40. PubMed ID: 12956408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidants and atherosclerosis.
    Niki E
    Biochem Soc Trans; 2004 Feb; 32(Pt 1):156-9. PubMed ID: 14748738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage foam cell formation during early atherogenesis is determined by the balance between pro-oxidants and anti-oxidants in arterial cells and blood lipoproteins.
    Aviram M
    Antioxid Redox Signal; 1999; 1(4):585-94. PubMed ID: 11233155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.